What are the limitations of the scd risk tcd?

While the scd risk tcd is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the scd risk tcd to ensure safe bedside use and optimal diagnostic accuracy.

How does the scd risk tcd compare to other hematology scores?

The scd risk tcd is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the scd risk tcd free to use?

Yes. OpiCalc provides the scd risk tcd completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

Sickle Cell Disease Risk (TCD)

SCD TCD Risk: Transcranial Doppler (TCD) velocity is the most potent predictor of stroke in children with HbSS/HbSβ⁰.

TCD TAM Velocity (cm/sec)

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Annual screening of children with Sickle Cell Anemia (HbSS) or Sickle Beta-0 Thalassemia (HbSβ⁰) to assess stroke risk.

Identifying candidates for chronic transfusion programs to prevent primary stroke.

Monitoring response to therapy (Hydroxurea or transfusion) in patients with conditional velocities.

Patient Population

Children with HbSS or HbSβ⁰ aged 2 to 16 years. (Note: standard screening usually stops at age 16, though risk remains).

Section 2

Formula & Logic

TCD Time-Averaged Maximum (TAM) Velocity

Velocity (cm/s)	Classification	Management
< 170	Normal	Repeat TCD annually.
170 - 199	Conditional	Repeat TCD every 3–6 months. Consider Hydroxyurea.
≥ 200	Abnormal	High risk of stroke (10% per year). Initiate chronic transfusion program.

Inadequate Study

If a TCD study is technically inadequate or uses non-imaging TCD when imaging TCD is indicated, thresholds may vary. Standard STOP criteria apply to non-imaging TCD velocities in the middle cerebral or carotid arteries.

Section 3

Pearls/Pitfalls

The STOP Trial Legacy

The STOP trial (Stroke Prevention Trial in Sickle Cell Anemia) demonstrated a 92% relative risk reduction in primary stroke when children with abnormal TCDs were placed on chronic transfusion programs compared to standard care.

Hydroxurea (TWITCH Trial)

In children with a previous TCD ≥ 200 who have completed at least 1 year of transfusion and have no stenotic vasculopathy on MRA, switching to high-dose Hydroxyurea is a non-inferior alternative to ongoing transfusion (per TWITCH trial).

Section 4

Evidence Appraisal

Primary Score

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Adams RJ et al. • New England Journal of Medicine. 1998;339(1):5-11.

View Source

Section 5

Literature

Screening Epoch

TCD revolutionized sickle cell care by identifying high-risk children before they suffered devastating neurological insults, shifting the management paradigm toward primary prevention.

Last Comprehensive Review: 2026

Related Hematology Tools

Durie-Salmon Staging

AL Amyloidosis Staging

HCT-CI

EBMT Risk Score

DRI

MAGIC aGvHD Biomarker Score

CRS Grading

ICANS Grading

aGvHD Grading

NIH Chronic GvHD Scoring

Have feedback about this calculator?Let us know.